Men’s Wellness Panel Premium from Life Line Screening

The assigned page provides a clear $149.00 price, and official terms add HSA or FSA eligibility, no Medicare or insurance claims, a $50 late cancellation or rescheduling deduction, and a $15 mailed-results fee. Location-specific final charges and conditions remain unresolved.

The page clearly covers four markers aligned to its promoted chronic-risk purpose. It is not a complete kidney, diabetes, cardiovascular, inflammation, or prostate evaluation and does not specify the additional tests needed for those decisions.

The marker set is directly relevant to a focused kidney, glucose, cardiovascular, and prostate-risk conversation, and the page provides contextual explanations and a PSA limitation. The product does not provide diagnostic cutoffs or establish a complete clinical decision pathway.

The provider gives context for eGFR, PSA age-group interpretation, A1c, and hs-CRP, and physician review and abnormal-result follow-up provide a basic interpretation path. Current ranges, cutoffs, uncertainty, and report fields are not public.

The four analytes, finger-stick route, trained personnel, physician review, and CLIA laboratory statement make the collection model reasonably clear. Current assay identity, analytical performance, precision, reference intervals, and product-specific validation remain undisclosed.

No referral, community locations in the 48 contiguous states, a typical visit under 90 minutes, preparation instructions, and portal or mail delivery make access practical. The panel requires an in-person appointment and ZIP confirmation.

The current notices provide meaningful disclosure about health-data collection, use, sharing, consent, controls, rights, and retention principles. They do not give a fixed retention schedule for this panel or product-specific handling of specimens and records.

The exact route discloses four biomarkers, broad intended uses, finger-stick collection, PSA context, location warning, and a $149.00 price. Current laboratory, assays, validation, numerical reference ranges, current report sample, and final checkout conditions are not disclosed.